The Motley Fool··Cory RenauerGoodRx Stalls While Hims & Hers Surges: Telehealth Divergence Widens
GoodRx revenue declines 4.4% YoY despite strong Pharma Direct growth, while $HIMS accelerates with 59% revenue growth and expanding subscriber base.
HIMSGDRXtelehealthsubscriber growth